The FDA has given the nod to Philips for its MicroDose SI full-field digital mammography (FFDM) system.
This SI model has the capacity to do a single-shot spectroscopy along with the earlier capabilities of the original MicroDose.
Using X-ray photon-counting detectors, the MicroDose device performs breast tissue imaging at a relatively reduced dose compared to traditional mammography. This technology is capable of detecting tumors covered inside dense breast tissue, therefore this system will be a shot in the arm to radiologists.
MicroDose SI employs special photon-counting technology and is indeed a boon to clinicians in conducting examinations using low dose radiation without sacrificing the quality of images. Philips has also worked on advancing this technology with Single-Shot Spectral Imaging.